Search - tctmd.com

Displaying 501 - 520 of 870

Sort: Relevancy | Date

Presentation TCT 2017

Case #2 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS

Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni

November 01, 2017

Presentation TCT 2017

Case #2 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS

Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni

November 01, 2017

Presentation TCT 2017

Case #1 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD

Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora

November 01, 2017

Presentation TCT 2017

Case #1 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD

Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora

November 01, 2017

Presentation TCT 2017

Shared Decision-making is an Essential Component of the Modern-era Heart Team: Rationale and Integration with TAVR Clinical Practice

Presenter: Eberhard Grube, James B. Hermiller Jr., Megan Coylewright

November 01, 2017

Presentation TCT 2017

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Samir R. Kapadia, Ioanna Kosmidou

November 01, 2017

Presentation TCT 2017

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Samir R. Kapadia, David J. Moliterno

November 01, 2017

Presentation TCT 2017

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Samir R. Kapadia, Sameer Gafoor

November 01, 2017

Presentation TCT 2017

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Presenter: Samir R. Kapadia, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

Case #9 (With Discussion): Decision-making During CTO Intervention

Presenter: Fernando Alfonso, Nick Curzen, Lei Ge

November 01, 2017

Presentation TCT 2017

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Presenter: Samir R. Kapadia, Ashish Pershad

November 01, 2017

Presentation TCT 2017

Case #7 (With Discussion): Decision-making During LMCA Intervention

Presenter: Fernando Alfonso, Nick Curzen, Erick Schampaert

November 01, 2017

Presentation TCT 2017

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

Presenter: Deepak L. Bhatt, C. Michael Gibson, Pascal Vranckx

November 01, 2017

Presentation TCT 2017

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status

Presenter: Deepak L. Bhatt, C. Michael Gibson, Renato D. Lopes

November 01, 2017

Presentation TCT 2017

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice

Presenter: Deepak L. Bhatt, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice?

Presenter: Deepak L. Bhatt, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

Presenter: Lee N. Benson, Megan Coylewright

November 01, 2017

Presentation TCT 2017

When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies

Presenter: Robert A. Harrington, Kurt Huber, Michael D. Ezekowitz

November 01, 2017

Presentation TCT 2017

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI

Presenter: Robert A. Harrington, Kurt Huber, Christopher B. Granger

November 01, 2017

Presentation TCT 2017

DECISION-CTO and EURO-CTO: Critique and Unanswered Questions

Presenter: David J. Cohen, Ajay J. Kirtane, Emmanouil S. Brilakis

November 01, 2017

Advertisement

Case #2 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS

Case #2 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS

Case #1 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD

Case #1 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD

Shared Decision-making is an Essential Component of the Modern-era Heart Team: Rationale and Integration with TAVR Clinical Practice

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Case #9 (With Discussion): Decision-making During CTO Intervention

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Case #7 (With Discussion): Decision-making During LMCA Intervention

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice?

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI

DECISION-CTO and EURO-CTO: Critique and Unanswered Questions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content